ArticleJournal of hypertension2026
Update from the National Hypertension Taskforce of Australia: prevalence, treatment and control rates of hypertension between 2022 and 2024 - implications and future directions.
Article in Journal of hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High blood pressure is the dominant risk factor for cardiovascular diseases and death in Australia. The blood pressure control rate in Australia was reported at 32% based on 2017-2018 data, which is substantially lower than other high-income countries. New results from the National Health Survey show an improvement of the crude control rate to 39.6% in the years 2022-2023, though changes in methodology need to be considered in the interpretation. Hypertension prevalence has increased from 33.7 to 39.4%. The prevalence and control rates vary strongly across diverse population groups. The age-standardized prevalence among First Nations peoples is higher than in the general population (37.8 versus 35%), and age-standardized blood pressure control rates are lower (22.2 versus 31.1%). Younger individuals and those in socioeconomically disadvantaged areas have substantially lower control rates, highlighting the need for greater equity to achieve the National Hypertension Taskforce's goal of 70% blood pressure control by 2030.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.